Melbourne has been selected to host the World Conference on Lung Cancer, the largest global gathering focused on lung cancer research and treatment. Scheduled for 2029, the conference will take place at the Melbourne Convention and Exhibition Centre (MCEC) and is anticipated to attract over 6,500 experts from approximately 100 countries. The event is projected to contribute more than $34 million to the local economy.
The conference is organized by the International Association for the Study of Lung Cancer (IASLC), the only global network dedicated to advancing research and finding solutions for lung cancer and other thoracic malignancies. The successful bid for this prestigious event was facilitated by the Melbourne Convention Bureau (MCB), which collaborated with the IASLC and Cancer Council Victoria. Support from the state government and Business Events Australia further solidified Melbourne’s position as a leading destination for international medical conferences.
Economic and Social Impact
MCB Chief Executive Julia Swanson expressed enthusiasm about the announcement, highlighting the importance of such conferences in fostering collaboration and knowledge exchange. “Hosting international medical conferences here not only drives knowledge exchange and collaboration but also delivers significant economic and social benefits to the city and the wider community,” Ms Swanson stated.
The significance of hosting this conference extends beyond economic contributions. Todd Harper, Chief Executive of Cancer Council Victoria, emphasized Australia’s established role in global efforts to combat lung cancer. “Bringing the world’s leading experts together here provides a powerful opportunity to accelerate progress and ultimately save more lives from lung cancer,” Mr Harper noted.
This conference represents a critical opportunity for researchers and healthcare professionals to share the latest advancements in lung cancer treatment and prevention. It will serve as a platform for discussions on innovative research, therapeutic strategies, and the future of lung cancer care globally.
As preparations begin, the local community and healthcare stakeholders are poised to engage with the international delegates, fostering an environment of shared knowledge and collaboration that aims to make a lasting impact on lung cancer research and treatment.
